Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Therapeutic Iontophoresis of Treprostinil in Systemic Sclerosis Digital UlcErations. A Proof of Concept Study

NCT03120533 is registered in ClinicalTrials.gov with University Hospital, Grenoble as lead sponsor.

NCT NCT03120533
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03120533 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Therapeutic Iontophoresis of Treprostinil in Systemic Sclerosis Digital UlcErations. A Proof of Concept Study
Lead sponsor
University Hospital, Grenoble
Phase
Phase 1/2
Overall status
Completed
Start date
June 20, 2017
Completion date
June 3, 2019
Enrollment
18 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

scleroderma, systemic